122 results
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
Laws; and (b) any petroleum or petroleum-derived products, radon, radioactive materials or wastes, asbestos in any form, lead or lead-containing … materials, urea formaldehyde foam insulation, and polychlorinated biphenyls.
“Healthcare Action” has the meaning set forth in Section 4.15(c).
“Healthcare
425
EX-99.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
in the Registration Statement, the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available. Shareholders
425
6p2fr6exa3nzcwa1kyj4
26 May 23
Business combination disclosure
5:14pm
8-K
EX-2.1
zaj ip8d55
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-99.1
mcfas
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
2nhf0t2
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
D
baods 839sun
14 Dec 22
$3.40 mm in debt / options, 12 investors
4:54pm
8-K
EX-10.1
3b2lj27e6ckjx7t0
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-10.2
v0sf95cn
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
emnh5lu
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
35acxuhjx16q8e 56nwg
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
DEF 14C
n7j6y8q2tj4iug
2 Jun 22
Information statement
9:15am